| scholarly article | Q13442814 |
| P50 | author | Taiki Aoshi | Q92914658 |
| P2093 | author name string | Jie Meng | |
| Ryo Suzuki | |||
| Yasunari Haseda | |||
| Lisa Munakata | |||
| P2860 | cites work | Adjuvant System AS03 containing α-tocopherol modulates innate immune response and leads to improved adaptive immunity. | Q30398841 |
| Enantiospecific adjuvant activity of cationic lipid DOTAP in cancer vaccine | Q33912706 | ||
| GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives | Q34655188 | ||
| Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists | Q34942985 | ||
| Recent advances in the discovery and delivery of vaccine adjuvants | Q35209997 | ||
| Personalized vaccines for cancer immunotherapy. | Q52641910 | ||
| Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response | Q57955486 | ||
| Immunocorrelates of CAF family adjuvants | Q58618296 | ||
| Diffusion of univalent ions across the lamellae of swollen phospholipids | Q59447717 | ||
| Microfluidic-Based Manufacture of siRNA-Lipid Nanoparticles for Therapeutic Applications | Q59900455 | ||
| A simple but effective cancer vaccine consisting of an antigen and a cationic lipid | Q80854720 | ||
| Shaping of adaptive immune responses to soluble proteins by TLR agonists: a role for IFN-alpha/beta | Q81022617 | ||
| Antigen Priming with Enantiospecific Cationic Lipid Nanoparticles Induces Potent Antitumor CTL Responses through Novel Induction of a Type I IFN Response | Q91750863 | ||
| Cancer Vaccines: Steering T Cells Down the Right Path to Eradicate Tumors | Q92310063 | ||
| Immunotherapeutic uses of CpG oligodeoxynucleotides | Q35730784 | ||
| Cationic liposomes extend the immunostimulatory effect of CpG oligodeoxynucleotide against Burkholderia pseudomallei infection in BALB/c mice | Q35940681 | ||
| T cell vaccines for microbial infections | Q36090185 | ||
| Vaccine Adjuvants: Putting Innate Immunity to Work | Q36168232 | ||
| Microfluidic Synthesis of Highly Potent Limit-size Lipid Nanoparticles for In Vivo Delivery of siRNA. | Q36234343 | ||
| A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing | Q36711264 | ||
| Type I interferon as a stimulus for cross-priming | Q37027815 | ||
| The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8(+) T-cell responses: The immunological consequences of the biodistribution profile | Q37294444 | ||
| New horizons in adjuvants for vaccine development | Q37342049 | ||
| ISCOMs and ISCOMATRIX. | Q37486921 | ||
| Combination adjuvants: the next generation of adjuvants? | Q37821483 | ||
| License to kill: Formulation requirements for optimal priming of CD8(+) CTL responses with particulate vaccine delivery systems | Q37925900 | ||
| Vaccine adjuvant formulations: a pharmaceutical perspective | Q38121281 | ||
| Combination of adjuvants: the future of vaccine design | Q38124060 | ||
| Nanoparticle vaccines | Q38167942 | ||
| Key roles of adjuvants in modern vaccines | Q38169040 | ||
| IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines | Q38289507 | ||
| Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and -independent pathways | Q38326606 | ||
| Controllable synthesis of functional nanoparticles by microfluidic platforms for biomedical applications - a review. | Q39043037 | ||
| T cell-dependent antigen adjuvanted with DOTAP-CpG-B but not DOTAP-CpG-A induces robust germinal center responses and high affinity antibodies in mice | Q40111632 | ||
| Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines | Q40128844 | ||
| Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction | Q40437839 | ||
| Distribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice | Q41695957 | ||
| High-throughput manufacturing of size-tuned liposomes by a new microfluidics method using enhanced statistical tools for characterization | Q41748148 | ||
| Induction of CD8+ T-cell responses against subunit antigens by the novel cationic liposomal CAF09 adjuvant | Q42213097 | ||
| Towards personalized, tumour-specific, therapeutic vaccines for cancer. | Q47789519 | ||
| Features of Effective T Cell-Inducing Vaccines against Chronic Viral Infections | Q50335281 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | nanoparticle | Q61231 |
| microfluidics | Q138845 | ||
| DOTAP | Q27284189 | ||
| P304 | page(s) | e0227891 | |
| P577 | publication date | 2020-01-24 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Microfluidic-prepared DOTAP nanoparticles induce strong T-cell responses in mice | |
| P478 | volume | 15 |
| Q98291992 | Comprehensive Screening of Mouse T-Cell Epitopes in Human Herpesvirus 6B Glycoprotein H/L/Q1/Q2 Tetramer Complex | cites work | P2860 |
Search more.